|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169.73 USD | +0.23% |
|
+2.94% | +84.63% |
| 08:52am | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| 07:40am | Royalty Pharma Acquires Royalty Interest in AstraZeneca's Cliramitug | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,270.37 | +8.08% | 27 | ||||||
| 269.95 | +7.72% | 22 | ||||||
| 266.57 | +4.09% | 28 | ||||||
| 359.22 | +7.62% | 18 | ||||||
| 152.19 | -1.55% | 21 | ||||||
| 317.2 | -2.11% | 24 | ||||||
| 356.69 | -2.61% | 29 | ||||||
| 157.59 | +20.96% | 27 | ||||||
| 28.75 | +15.27% | 26 | ||||||
| 62.96 | +3.33% | 24 | ||||||
| 554.91 | +15.13% | 23 | ||||||
| 96.31 | +25.49% | 23 | ||||||
| 21.39 | +13% | 20 | ||||||
| 9,853.33 | +33.21% | 15 | ||||||
| 80.52 | +46.59% | 15 | ||||||
| 6,126.87 | +10.29% | 15 | ||||||
| 54.92 | +15.32% | 18 | ||||||
| 4.142 | +12.38% | 17 | ||||||
| 432.91 | +59.53% | 23 | ||||||
| Average | 1,077.2 | +15.35% | 22 | ||||||
| Weighted average by Cap. | 743.68 | +8.78% | 24 |
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Sector AstraZeneca PLC
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
